Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni DI Zenzo

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Dermatology Practical & Conceptual|February 28, 2022
Pemphigus Vulgaris: Present and Future Therapeutic StrategiesDario Didona, Giovanni Paolino, Giovanni Di Zenzo, et al.
Frontiers in Immunology|August 15, 2022
Case report: bullous pemphigoid development underlies dystrophic epidermolysis bullosa disease worseningGiovanni Di Zenzo, Giovanna Floriddia, Sabrina Rossi, et al.
Vaccines|September 28, 2024
COVID-19 Vaccine: A Potential Risk Factor for Accelerating the Onset of Bullous PemphigoidAnna Pira, Feliciana Mariotti, Francesco Moro, et al.
Frontiers in Immunology|May 3, 2021
Case Report: Complete and Fast Recovery From Severe COVID-19 in a Pemphigus Patient Treated With RituximabJo Linda Sinagra, Claudio Vedovelli, Raffaella Binazzi, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 20, 2004
Mammalian cell transduction and internalization properties of lambda phages displaying the full-length adenoviral penton base or its central domainStefania Piersanti, Gioia Cherubini, Yuri Martina, et al.
Frontiers in Medicine|January 12, 2024
Pemphigus: trigger and predisposing factorsFrancesco Moro, Jo Linda Maria Sinagra, Adele Salemme, et al.
Clinical Immunology (Orlando, Fla.)|December 5, 2006
Oral pemphigoid autoantibodies preferentially target BP180 ectodomainValentina Calabresi, Marco Carrozzo, Emanuele Cozzani, et al.
The Journal of Dermatology|July 15, 2018
Bullous pemphigoid with hyperkeratosis and palmoplantar keratoderma: Three casesLuca Fania, Dario Didona, Valeria Pacifico, et al.
Dermatology Reports|September 27, 2023
Environmental factors in autoimmune bullous diseases with a focus on seasonality: new insightsRoberto D'Astolto, Lavinia Quintarelli, Alberto Corrà, et al.
European Journal of Dermatology : EJD|November 11, 2015
The pathogenic activity of anti-desmoglein autoantibodies parallels disease severity in rituximab-treated patients with pemphigus vulgarisAnna Sinistro, Valentina Calabresi, Francesca Lupi, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Dermatology Practical & Conceptual|February 28, 2022
Pemphigus Vulgaris: Present and Future Therapeutic StrategiesDario Didona, Giovanni Paolino, Giovanni Di Zenzo, et al.
Frontiers in Immunology|August 15, 2022
Case report: bullous pemphigoid development underlies dystrophic epidermolysis bullosa disease worseningGiovanni Di Zenzo, Giovanna Floriddia, Sabrina Rossi, et al.
Vaccines|September 28, 2024
COVID-19 Vaccine: A Potential Risk Factor for Accelerating the Onset of Bullous PemphigoidAnna Pira, Feliciana Mariotti, Francesco Moro, et al.
Frontiers in Immunology|May 3, 2021
Case Report: Complete and Fast Recovery From Severe COVID-19 in a Pemphigus Patient Treated With RituximabJo Linda Sinagra, Claudio Vedovelli, Raffaella Binazzi, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 20, 2004
Mammalian cell transduction and internalization properties of lambda phages displaying the full-length adenoviral penton base or its central domainStefania Piersanti, Gioia Cherubini, Yuri Martina, et al.
Frontiers in Medicine|January 12, 2024
Pemphigus: trigger and predisposing factorsFrancesco Moro, Jo Linda Maria Sinagra, Adele Salemme, et al.
Clinical Immunology (Orlando, Fla.)|December 5, 2006
Oral pemphigoid autoantibodies preferentially target BP180 ectodomainValentina Calabresi, Marco Carrozzo, Emanuele Cozzani, et al.
The Journal of Dermatology|July 15, 2018
Bullous pemphigoid with hyperkeratosis and palmoplantar keratoderma: Three casesLuca Fania, Dario Didona, Valeria Pacifico, et al.
Dermatology Reports|September 27, 2023
Environmental factors in autoimmune bullous diseases with a focus on seasonality: new insightsRoberto D'Astolto, Lavinia Quintarelli, Alberto Corrà, et al.
European Journal of Dermatology : EJD|November 11, 2015
The pathogenic activity of anti-desmoglein autoantibodies parallels disease severity in rituximab-treated patients with pemphigus vulgarisAnna Sinistro, Valentina Calabresi, Francesca Lupi, et al.
Pageof 8